Denisa Russell
Medical · Prosper, TXNPI 1750628798
Payments from drug & device makers
Across 387 payments — averaging $29.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Arcutis Biotherapeutics, Inc.$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
- E.r. Squibb & Sons, L.L.C.$813
- Sun Pharmaceutical Industries Inc.$671
- LEO Pharma Inc.$667
- plus $5K from 26 others
What the payments were for
- Consulting fees$2,02518%
- Food & beverage$8,83479%
- Education$3913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 82 | $1,523 |
| Arcutis Biotherapeutics, Inc. | 21 | $1,520 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $1,185 |
| E.r. Squibb & Sons, L.L.C. | 23 | $813 |
| Sun Pharmaceutical Industries Inc. | 26 | $671 |
| LEO Pharma Inc. | 16 | $667 |
| Novartis | 20 | $664 |
| Lilly USA, LLC | 31 | $653 |
| Johnson & Johnson | 17 | $532 |
| Regeneron Healthcare Solutions, Inc. | 16 | $347 |
| Pfizer | 19 | $334 |
| Galderma Laboratories, L.p. | 15 | $267 |
| Journey Medical Corporation | 1 | $250 |
| Amgen | 9 | $240 |
| Dermavant Sciences, Inc. | 9 | $229 |
| Sanofi | 6 | $226 |
| UCB, Inc. | 8 | $184 |
| Organon | 10 | $177 |
| Incyte Corporation | 8 | $169 |
| Mayne Pharma Commercial LLC | 13 | $113 |
| Merz North America, Inc. | 2 | $93 |
| Almirall LLC | 5 | $90 |
| Novo Nordisk | 3 | $50 |
| Kerecis Limited | 2 | $49 |
| Biofrontera Inc. | 2 | $45 |
| Angiodynamics, Inc. | 2 | $41 |
| Dermira, Inc. | 2 | $34 |
| Botanix SB Inc | 1 | $24 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $16 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,250 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 21 | $323 |
| Clobetasol Propionate | 13 | $299 |
Paid to pharmacies, not to this prescriber.
Other medical in Prosper
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.